Flonase allergy relief and Device failure - a phase IV clinical study of FDA data

Summary:

Device failure is reported as a side effect among people who take Flonase allergy relief (fluticasone propionate), especially for people who are female, 60+ old, also take Remodulin, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Device failure when taking Flonase allergy relief. It is created by eHealthMe based on reports of 9,502 people who have side effects when taking Flonase allergy relief from the FDA, and is updated regularly.

What is Flonase allergy relief?

Flonase allergy relief has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 9,599 Flonase allergy relief users. Check the latest studies of Flonase allergy relief.

What is Device failure?

Device failure is found to be associated with 751 drugs and 761 conditions by eHealthMe. Check the latest studies of Device failure.

On Jul, 10, 2026

9,502 people reported to have side effects when taking Flonase allergy relief.
Among them, 18 people (0.19%) have Device failure.

Could Flonase allergy relief cause Device failure?

Among these 18 people:

What is the gender of people who have Device failure when taking Flonase allergy relief? *

female: 82.35 %
male: 17.65 %

What is the age of people who have Device failure when taking Flonase allergy relief? *

What are other drugs people take besides Flonase allergy relief? *

Remodulin: 18 people, 100.00%
Gabapentin: 16 people, 88.89%
Lidocaine Hydrochloride: 15 people, 83.33%
Sodium Chloride: 15 people, 83.33%
Ketamine Hydrochloride: 15 people, 83.33%
Ketoprofen: 15 people, 83.33%
Lecithin: 14 people, 77.78%
Clonidine: 13 people, 72.22%
Albuterol Sulfate: 11 people, 61.11%
Amitriptyline Hydrochloride: 11 people, 61.11%

What are other side effects people have besides Device failure? *

Infusion Site Pain: 11 people, 61.11%
Infusion Site Infection: 7 people, 38.89%
Pain: 6 people, 33.33%
Infusion Site Bruising: 6 people, 33.33%
Infusion Site Erythema (reddening of the skin at infusion site): 6 people, 33.33%
Infusion Site Swelling: 5 people, 27.78%
Malaise (a feeling of general discomfort or uneasiness): 5 people, 27.78%
Fatigue (feeling of tiredness): 4 people, 22.22%
Dyspnea (difficult or laboured breathing): 4 people, 22.22%
Diarrhea: 4 people, 22.22%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 18 people, 100.00%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 5.56%
Infusion Site Pain: 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Flonase allergy relief and have Device failure?

- Check whether Device failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flonase allergy relief:

Flonase allergy relief (9,599 reports)

Device failure treatments and more:

Device failure (17,275 reports)

Browse all side effects of Flonase allergy relief:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Device failure:

Device failure (752 drugs)

Browse all the conditions that are associated with Device failure:

Device failure (761 conditions)

Related publications that referenced our studies

Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .
Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on fluticasone propionate (the active ingredients of Flonase allergy relief) and Flonase allergy relief (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.